デフォルト表紙
市場調査レポート
商品コード
1777418

小児心臓腫瘍診断の世界市場

Pediatric Cardiac Tumor Diagnostics


出版日
ページ情報
英文 376 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.67円
小児心臓腫瘍診断の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 376 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

小児心臓腫瘍診断の世界市場は2030年までに9億4,610万米ドルに達する見込み

2024年に6億6,270万米ドルと推定される小児心臓腫瘍診断の世界市場は、2024~2030年の分析期間にCAGR 6.1%で成長し、2030年には9億4,610万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである原発性Cardiac Tumorsは、CAGR 4.9%を記録し、分析期間終了までに5億6,690万米ドルに達すると予測されます。二次性心腫瘍セグメントの成長率は、分析期間中CAGR 8.1%と推定されます。

米国市場は1億8,060万米ドルと推定、中国はCAGR9.4%で成長予測

米国の小児心臓腫瘍診断市場は、2024年に1億8,060万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 9.4%を牽引し、2030年には1億9,100万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1%と5.9%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の小児心臓腫瘍診断市場- 主要動向と促進要因のまとめ

レアはどのように関連してきているのか?小児心臓腫瘍の早期診断への注目の高まり

小児心臓腫瘍は、乳幼児や小児に認められる心臓血管の異常の中でも最も稀ではあるが最も重篤なもの一つであり、しばしば診断や治療に重大な課題をもたらします。小児集団における原発性心腫瘍の発生率は0.2%未満と推定されているが、診断の遅れや見逃しがもたらす影響は生命を脅かし、不整脈、心不全、または心臓突然死につながることがあります。歴史的には、診断は通常偶発的なものであり、無関係な症状の検査中や剖検中に発見されました。しかし、現在では、小児心臓病学プログラムの拡大や臨床医の意識の向上により、早期かつ的を絞った診断へと明らかにシフトしています。胎児および新生児心エコー検査の進歩により、出生前であっても心臓腫瘍、特にサイズが大きいものや心機能を阻害するものを発見できるようになってきています。横紋筋腫、線維腫、粘液腫は小児に最もよくみられる良性腫瘍であり、それぞれ診断プロファイルが異なるため、画像診断と解釈には高度に調整されたアプローチが必要です。臨床の場では、小児科医や循環器専門医は、雑音、チアノーゼ、再発性失神などの微妙な徴候を認識するための訓練を受けています。特に心臓横紋筋腫としばしば関連する結節性硬化症症候群のような症候群では、遺伝カウンセリングの統合が進んでおり、早期診断に積極的な層が加わっています。生存率が向上し、臨床サーベイランスがより強固になるにつれて、小児心臓腫瘍診断は反応的な領域から予防的な領域へと移行しつつあり、小児ヘルスケアシステムにおけるその重要性が世界的に高まっていることを示しています。

なぜ画像診断が進歩の中心なのか?小児心臓診断における技術革命を探る

小児心臓腫瘍診断の技術的状況は劇的に進化しており、非侵襲的な画像診断が発見とモニタリングの両面で中心的な役割を担っています。心エコー検査は、その安全性、携帯性、高解像度のリアルタイムイメージング機能により、依然として初期評価の要となっています。3D心エコーとドップラー法の革新は、腫瘍の大きさ、位置、血行動態への影響に関する詳細な解剖学的および機能的洞察を提供することにより、診断精度を高めています。心臓磁気共鳴画像法(MRI)は、特に腫瘍の種類を鑑別し、血栓や他の腫瘤と区別するための優れた組織特性を提供し、重要な補助装置として台頭してきました。T1、T2マッピングや後期ガドリニウム増強などの高度なシーケンスは、腫瘍の断端や浸潤をより正確に描出することを可能にし、手術計画やリスク評価に極めて重要です。さらに、心臓コンピュータ断層撮影(CT)は、その放射線被曝にもかかわらず、腫瘍の形態や冠動脈解剖の迅速な3D可視化が必要な複雑な症例やあいまいな症例で使用されることが多くなっています。画像解析に人工知能や機械学習アルゴリズムを取り入れることで、特に3次小児医療センターでは、パターン認識や診断標準化のための新たな道が開かれつつあります。PET-MRIフュージョン画像や造影超音波などの新しいモダリティも、解剖学的評価と代謝評価のギャップを埋めるために研究されています。これらの技術的進歩は診断の信頼性を向上させるだけでなく、多くの症例で心臓カテーテル検査や生検のような侵襲的手技の必要性を減らしています。画像診断がより洗練され、デジタル的に統合されるにつれて、放射線科医と小児循環器科医の役割は、これらの生命に影響を与える腫瘍をタイムリーかつ正確に診断することを目的とした、より協力的でデータ主導型のパートナーシップへと進化しつつあります。

多職種連携は小児心臓腫瘍の診断ワークフローを再構築するか?

小児心臓腫瘍の複雑な性質により、診断、リスク層別化、ケアパスの合理化において集学的連携が不可欠となっています。小児心臓腫瘍の診断は、しばしば小児心臓専門医、心臓外科医、腫瘍専門医、放射線科医、病理医、遺伝専門医、および重症治療専門医の協調的関与の引き金となります。このようなチームベースのアプローチは、主要な小児病院や心臓専門施設では標準治療となりつつあります。画像所見を検討し、手術の実行可能性を評価し、フォローアッププロトコルを決定するために、これらの専門分野からなる腫瘍委員会が招集されるようになってきています。さらに、遺伝子プロファイリングは、特にカーニーコンプレックスやゴーリン症候群のような疾患において、症候学的関連、遺伝性変異、潜在的な再発リスクを同定するために診断に組み込まれつつあります。腫瘍生検は侵襲的な性質とそれに伴うリスクのために禁忌とされることが多いため、病理組織学的な洞察は通常、画像診断と臨床データから推測されます。小児心臓腫瘍学の台頭は、専門分野を超えた意思決定の共有の必要性をさらに際立たせています。遠隔医療プラットフォームやデジタル症例共有ツールは、特にセカンドオピニオンを必要とするまれな症例やあいまいな症例について、リアルタイムで専門家パネルに遠隔参加することも可能にしています。小児の心臓腫瘍の発見が精神的な影響を与えることを認識し、親によるカウンセリングや心理社会的サポートが診断の旅に組み込まれるようになってきています。集学的治療へのこのような体系的なシフトは、診断のタイムラインと精度を向上させるだけでなく、生存と生活の質の両方を最適化する個別化された治療戦略を促進します。医療機関においてケアの統合が重視されるようになり、小児心臓腫瘍の診断ワークフローはよりまとまり、連携し、患者を中心としたものとなりつつあります。

小児心臓腫瘍診断市場の成長はいくつかの要因によって牽引されている...

小児心臓腫瘍診断市場の成長は、診断イノベーション、臨床使用事例の拡大、消費者の期待の進化を中心としたいくつかの要因によって牽引されています。特に、3D心エコー、高磁場心臓MRI、ハイブリッドイメージング技術の普及は、早期発見率と診断精度を大幅に向上させ、市場浸透を拡大させています。最終用途の観点からは、小児専門病院、胎児心臓病プログラム、小児腫瘍センターの普及が進み、高解像度でマルチパラメトリックな診断ツールに対する需要が高まっています。もう1つの主要な推進力は、心臓病学のワークフローに遺伝子診断や分子診断が統合されつつあることで、腫瘍素因や関連症候群の事前予防的な特定が可能になっています。ヘルスケアプロバイダーはまた、クラウドベースの画像管理システムとAIを強化した分析プラットフォームに多額の投資を行っています。これらのシステムは、共同診断をサポートし、解釈エラーを減らし、多施設のヘルスケアネットワーク間での報告を合理化します。小児心臓のまれな症例に関する臨床医の意識の向上と継続的な教育プログラムが、画像診断のための紹介頻度と精度を高めています。さらに、新生児スクリーニングや出生前スクリーニングの取り組みが加速しているため、心臓腫瘍がより早い段階で診断の対象となり、より良好な介入時期がもたらされています。消費者側では、親が小児医療に関する意思決定に関与するようになり、迅速かつ非侵襲的で正確な診断オプションを期待する傾向が強まっています。さらに、小児科研究への投資の増加や国際的な共同研究は、エビデンスに基づく診断ガイドラインの開発を促進し、その結果、ヘルスケアシステム全体の機器のアップグレードやプロトコルの標準化に影響を及ぼしています。これらの多面的な要因が相まって、小児心臓腫瘍診断市場の成長が促進されるだけでなく、稀ではあるが重要な疾患へのアプローチ、発見、管理方法が世界中で再構築されつつあります。

セグメント

腫瘍(原発性心臓腫瘍、二次性心臓腫瘍);種類(心エコー、磁気共鳴画像、コンピュータ断層撮影スキャン、その他);エンドユーザー(病院&クリニック、政府保健局、その他)

調査対象企業の例

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CardioComm Solutions
  • Circle Cardiovascular Imaging
  • Elekta
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Medical Systems
  • GE Healthcare
  • Hitachi Medical Systems
  • Lantheus Medical Imaging
  • Medtronic
  • Philips Healthcare
  • Pie Medical Imaging
  • Samsung Medison
  • Shimadzu Corporation
  • Siemens Healthineers
  • Sophia Genetics
  • Varian Medical Systems

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32502

Global Pediatric Cardiac Tumor Diagnostics Market to Reach US$946.1 Million by 2030

The global market for Pediatric Cardiac Tumor Diagnostics estimated at US$662.7 Million in the year 2024, is expected to reach US$946.1 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Primary Cardiac Tumors, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$566.9 Million by the end of the analysis period. Growth in the Secondary Cardiac Tumors segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$180.6 Million While China is Forecast to Grow at 9.4% CAGR

The Pediatric Cardiac Tumor Diagnostics market in the U.S. is estimated at US$180.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$191.0 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Pediatric Cardiac Tumor Diagnostics Market - Key Trends & Drivers Summarized

How Is Rare Becoming Relevant? The Surging Focus on Early Diagnosis of Pediatric Cardiac Tumors

Pediatric cardiac tumors are among the rarest but most serious cardiovascular abnormalities observed in infants and children, often presenting significant diagnostic and treatment challenges. While the incidence of primary cardiac tumors in the pediatric population is estimated at less than 0.2%, the implications of delayed or missed diagnosis can be life-threatening, leading to arrhythmias, heart failure, or sudden cardiac death. Historically, diagnosis was typically incidental, discovered during investigations for unrelated symptoms or during autopsies. However, there is now a clear shift towards early, targeted diagnostics driven by the expansion of pediatric cardiology programs and increased clinician awareness. Advances in fetal and neonatal echocardiography are enabling the detection of cardiac tumors even before birth, especially those with large sizes or those obstructing cardiac function. Rhabdomyomas, fibromas, and myxomas are the most common benign tumors found in children, each presenting distinct diagnostic profiles that necessitate a highly tailored approach to imaging and interpretation. In the clinical setting, pediatricians and cardiologists are increasingly trained to recognize subtle signs-such as murmurs, cyanosis, or recurrent syncope-that may warrant deeper investigation. The growing integration of genetic counseling, particularly in syndromes like tuberous sclerosis complex, which is frequently associated with cardiac rhabdomyomas, also adds a proactive layer to early diagnosis. As survival rates improve and clinical surveillance becomes more robust, pediatric cardiac tumor diagnostics are transitioning from a reactive to a preventative domain, underscoring their rising relevance in pediatric healthcare systems globally.

Why Is Imaging at the Heart of Progress? Exploring the Technological Revolution in Pediatric Cardiac Diagnostics

The technological landscape for pediatric cardiac tumor diagnostics has evolved dramatically, with non-invasive imaging modalities taking center stage in both detection and monitoring. Echocardiography remains the cornerstone of initial assessment due to its safety, portability, and high-resolution real-time imaging capabilities. Innovations in 3D echocardiography and Doppler modalities are enhancing diagnostic accuracy by providing detailed anatomical and functional insights into tumor size, location, and hemodynamic impact. Cardiac magnetic resonance imaging (MRI) has emerged as a critical adjunct, offering superior tissue characterization, particularly for differentiating between tumor types and distinguishing them from thrombi or other masses. Advanced sequences, such as T1 and T2 mapping and late gadolinium enhancement, are enabling more precise delineation of tumor margins and infiltration, crucial for surgical planning and risk assessment. Additionally, cardiac computed tomography (CT), despite its radiation exposure, is increasingly used in complex or ambiguous cases where rapid 3D visualization of tumor morphology and coronary anatomy is required. The incorporation of artificial intelligence and machine learning algorithms into image analysis is opening new avenues for pattern recognition and diagnostic standardization, particularly in tertiary pediatric centers. Emerging modalities such as PET-MRI fusion imaging and contrast-enhanced ultrasound are also being explored to bridge the gap between anatomical and metabolic assessment. These technological advances are not only improving diagnostic confidence but are also reducing the need for invasive procedures like cardiac catheterization or biopsy in many cases. As diagnostic imaging becomes more refined and digitally integrated, the role of radiologists and pediatric cardiologists is evolving into a more collaborative, data-driven partnership aimed at timely and precise diagnosis of these life-impacting tumors.

Is Multidisciplinary Collaboration Reshaping the Diagnostic Workflow for Pediatric Cardiac Tumors?

The complex nature of pediatric cardiac tumors has made multidisciplinary collaboration essential in streamlining diagnosis, risk stratification, and care pathways. A pediatric cardiac tumor diagnosis often triggers the coordinated involvement of pediatric cardiologists, cardiac surgeons, oncologists, radiologists, pathologists, geneticists, and critical care specialists. This team-based approach is becoming the standard of care at leading pediatric hospitals and specialized heart institutes. Tumor boards comprising these specialties are increasingly convened to review imaging findings, evaluate surgical feasibility, and decide on follow-up protocols. Furthermore, genetic profiling is being integrated into diagnostics to identify syndromic associations, inherited mutations, and potential recurrence risks, particularly in conditions like Carney complex or Gorlin syndrome. As tumor biopsies are often contraindicated due to their invasive nature and associated risks, histopathological insights are typically inferred from imaging and clinical data, making collaborative diagnostic interpretation all the more crucial. The rise of pediatric cardio-oncology as a sub-discipline is further highlighting the need for shared decision-making across specialties. Telemedicine platforms and digital case-sharing tools are also enabling remote participation of expert panels in real time, particularly for rare or ambiguous cases requiring second opinions. Parental counseling and psychosocial support are increasingly integrated into the diagnostic journey, recognizing the emotional impact of cardiac tumor detection in children. This systemic shift toward multidisciplinary care is not only improving diagnostic timelines and accuracy but also fostering individualized treatment strategies that optimize both survival and quality of life. With growing institutional emphasis on care integration, diagnostic workflows for pediatric cardiac tumors are becoming more cohesive, coordinated, and patient-centered.

The Growth in the Pediatric Cardiac Tumor Diagnostics Market Is Driven by Several Factors…

The growth in the pediatric cardiac tumor diagnostics market is driven by several factors centered on diagnostic innovation, expanding clinical use cases, and evolving consumer expectations. Technological advances in pediatric cardiac imaging-particularly the widespread adoption of 3D echocardiography, high-field cardiac MRI, and hybrid imaging techniques-are significantly improving early detection rates and diagnostic precision, thereby expanding market penetration. From an end-use perspective, the growing prevalence of pediatric specialty hospitals, fetal cardiology programs, and pediatric oncology centers is increasing demand for high-resolution and multiparametric diagnostic tools. Another key driver is the rising integration of genetic and molecular diagnostics into cardiology workflows, enabling proactive identification of tumor predispositions and associated syndromes. Healthcare providers are also investing heavily in cloud-based image management systems and AI-enhanced analytics platforms, which support collaborative diagnostics, reduce interpretation errors, and streamline reporting across multisite healthcare networks. Increasing clinician awareness and continuous education programs on rare pediatric cardiac presentations are boosting the frequency and accuracy of referrals for diagnostic imaging. Furthermore, the acceleration of newborn and prenatal screening initiatives is bringing cardiac tumors into the diagnostic spotlight at much earlier stages, leading to more favorable intervention windows. On the consumer front, parents are becoming more engaged in pediatric health decisions and increasingly expect swift, non-invasive, and accurate diagnostic options-a trend that is shaping procurement priorities and patient pathway designs. Additionally, rising investments in pediatric research and international collaborations are promoting the development of evidence-based diagnostic guidelines, which in turn are influencing equipment upgrades and protocol standardization across healthcare systems. Collectively, these multifaceted factors are not only catalyzing growth in the pediatric cardiac tumor diagnostics market but are also reshaping how these rare but critical conditions are approached, detected, and managed worldwide.

SCOPE OF STUDY:

The report analyzes the Pediatric Cardiac Tumor Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors); Type (Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan, Others); End-Use (Hospitals & Clinics, Government Health Department, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CardioComm Solutions
  • Circle Cardiovascular Imaging
  • Elekta
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Medical Systems
  • GE Healthcare
  • Hitachi Medical Systems
  • Lantheus Medical Imaging
  • Medtronic
  • Philips Healthcare
  • Pie Medical Imaging
  • Samsung Medison
  • Shimadzu Corporation
  • Siemens Healthineers
  • Sophia Genetics
  • Varian Medical Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pediatric Cardiac Tumor Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Rare Pediatric Cardiac Conditions Throws the Spotlight on Early Diagnostic Tools
    • Advancements in Pediatric Cardiac Imaging Propels Adoption of Non-Invasive Diagnostic Techniques
    • Increasing Availability of Fetal Echocardiography Drives Prenatal Detection of Cardiac Tumors
    • Expansion of Multidisciplinary Pediatric Cardiology Units Strengthens Business Case for Integrated Diagnostics
    • Growing Focus on Early Intervention Expands Addressable Market for Specialized Diagnostic Solutions
    • Development of AI-Based Imaging Analytics Accelerates Diagnostic Accuracy in Pediatric Tumor Cases
    • Rising Incidence of Congenital Heart Defects Generates Demand for Advanced Diagnostic Modalities
    • Enhanced Access to Pediatric Cardiac MRI and CT Scans Spurs Technology Adoption in Tertiary Hospitals
    • Integration of Genetic and Molecular Testing in Cardiac Diagnostics Drives Precision Medicine Strategies
    • Collaborative Research in Pediatric Oncology and Cardiology Throws Spotlight on Cross-Specialty Diagnostics
    • Increased Funding for Rare Disease Research Accelerates Innovation in Pediatric Cardiac Tumor Detection
    • Improved Survival Outcomes from Early Detection Strengthens Business Case for Screening Programs
    • Proliferation of Pediatric Cardiac Centers of Excellence Expands Market for Specialized Diagnostic Services
    • Emergence of Minimally Invasive Biopsy Techniques Propels Growth of Targeted Tumor Diagnostics
    • Standardization of Diagnostic Guidelines by Pediatric Societies Drives Market Formalization
    • Technological Innovations in Portable Ultrasound Devices Drive Access in Rural and Low-Resource Settings
    • Global Burden of Undiagnosed Pediatric Heart Tumors Spurs Investment in Screening Infrastructure
    • Advancement in 3D Echocardiography and Image Fusion Enhances Clinical Confidence in Diagnosis
    • Increasing Use of AI for Tumor Classification and Risk Stratification Strengthens Diagnostic Workflows
    • Regulatory Support for Pediatric Imaging Innovation Sustains Market Momentum for Specialized Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pediatric Cardiac Tumor Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Primary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Primary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Primary Cardiac Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Secondary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Secondary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Secondary Cardiac Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Computed Tomography Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Computed Tomography Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Computed Tomography Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Government Health Department by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Government Health Department by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Government Health Department by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION